Gadusol has been acquired since this press release was originally posted.

Corvallis, Oregon—July 10, 2019— Gadusol Laboratories today announced it has received a seed investment from Ideaship, a patent leveraged venture capital firm that provides patent development support for early stage startups. The investment will further assist Gadusol Laboratories’ commercialization journey.

“As the environmental damage to oceanic ecosystems caused by traditional chemical compounds becomes unignorable and skin cancer rates continue to climb, the commercialization of Gadusol’s novel technologies becomes increasingly urgent. We are excited to join the founding team of Gadusol. We were inspired by the team’s culture and innovation process under the leadership of Managing Director, Katie Pettinger,” commented Michael Lubitz.

“As Gadusol’s technology is commercialized, consumers will have access to a product that will protect them from harmful UV rays and related environmental hazards caused by traditional UV protectants,” said Kazutoshi Yasunaga, IP Specialist for Ideaship and Director for Panasonic Intellectual Property Corporation of America.

“Ideaship is a committed partner and we are grateful to be working with them as we take the first steps towards scaling manufacturing,” remarked Katie Pettinger, Managing Director of Gadusol Laboratories.

About Gadusol Laboratories

Gadusol Laboratories is a UV protectant engineering and manufacturing company based in Corvallis, Oregon. Their gadusol-based sunscreen additive is entirely natural, safe for humans, and has no negative impact on oceanic ecosystems. For more information, please visit

About Ideaship

Ideaship provides patent development capital for early stage ventures.

Ideaship is a collaboration between Global Technology Transfer Group (GTT Group) and Panasonic Intellectual Property Corporation of America. Ideaship combines the expertise and experience of GTT Group’s patent analysis, valuation, and monetization practices with Panasonic Intellectual Property Corporation of America’s leading patent department to achieve enterprise value premiums.

For more information, please visit